Search Results 631-640 of 21260 for anti-TNF drugs
Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...
“This study will tell us whether this gene plays an important role in determining response to anti-platelet therapy after coronary interventions.” Michael ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Lenvatinib is also used in combination with pembrolizumab injection as first-line treatment of advanced renal cell carcinoma (RCC), a kind of kidney cancer, ...
Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...
Mayo Clinic Comprehensive Cancer Center combines personalized cancer treatment with leading-edge research to provide you with unparalleled cancer care.
Mayo Clinic is developing ways to use nanoparticles to modify adipose-derived mesenchymal stem cells to secrete anti-tumor proteins. The therapy can then be ...
... drugs. Drug development out of reach for Mayo Clinic. Dr. Bram was well aware that the next steps in creating a therapy for brain cancers based on his ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.